XERIS BIOPHARMA HOLDINGS, INC. Income (Loss) from Continuing Operations before Income Taxes, Domestic
XERIS BIOPHARMA HOLDINGS, INC. (XERS) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$45.91 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-02
- XERIS BIOPHARMA HOLDINGS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$45.91M.
- XERIS BIOPHARMA HOLDINGS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$78.41M.
- XERIS BIOPHARMA HOLDINGS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$67.26M.
- XERIS BIOPHARMA HOLDINGS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$77.08M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2025-12-31 | -$45.91M 10-K · filed 2026-03-02 |
| 2024-12-31 | -$78.41M 10-K · filed 2026-03-02 |
| 2023-12-31 | -$67.26M 10-K · filed 2026-03-02 |
| 2022-12-31 | -$77.08M 10-K · filed 2025-03-06 |
| 2021-12-31 | -$114.74M 10-K · filed 2024-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |